A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib

A Poorly Differentiated Malignant Neoplasm Lacking Lung Markers Harbors an EML4-ALK Rearrangement and Responds to Crizotinib

Suspected metastatic site lesions that are poorly differentiated present a diagnostic challenge when morphologic and immunohistochemical profiling cannot establish the primary tumor site. Here we present a patient diagnosed with both a malignant neoplasm in the lung and a right upper extremity (RUE)...

Full description

Bibliographic Details
Main Authors: Chung, Jon H., Ali, Siraj M., Davis, Jenni, Robstad, Karl, McNally, Richard, Gay, Laurie M., Erlich, Rachel L., Palma, Norma A., Stephens, Phil J., Miller, Vincent A., Cutugno, Alfonso, Ross, Jeffrey S.
Format: Online
Language:English
Published: S. Karger AG 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209277/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209277/

Similar Items